A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS Herantis Pharma Plc Company release 11 July…

Read More

Herantis Pharma Plc's Board decision on new stock option program for senior employees

Herantis Pharma Plc's Board decision on new stock option program for senior employees Herantis Pharma Plc Company release 19 May…

Read More

Herantis Pharma initiates patient recruitment for clinical study with Lymfactin® in breast cancer associated lymphedema

Herantis Pharma initiates patient recruitment for clinical study with Lymfactin® in breast cancer associated lymphedema Herantis Pharma Plc Company release…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.